AI Engines For more Details: Perplexity Kagi Labs You
Butyrate Production: Eubacterium hallii is known to produce butyrate, a short-chain fatty acid (SCFA) that serves as an important energy source for colonocytes (cells lining the colon) and plays a key role in maintaining gut health. Butyrate has anti-inflammatory properties and helps regulate immune function in the gut.
Metabolic Health: Some research suggests that Eubacterium hallii may be involved in metabolic processes related to energy metabolism and nutrient absorption. Changes in the abundance of Eubacterium hallii have been observed in individuals with metabolic disorders such as obesity and type 2 diabetes, although the exact implications of these changes are not fully understood.
Gut Microbiota Composition: Eubacterium hallii is part of the normal gut microbiota in healthy individuals. Its presence and abundance may contribute to the overall balance and diversity of the gut microbiome, which is important for various aspects of health, including digestion, immune function, and metabolism.
Butyrate and Intestinal Barrier Function: Butyrate produced by Eubacterium hallii and other gut bacteria helps maintain the integrity of the intestinal barrier, which serves as a protective barrier against pathogens and toxins. A healthy intestinal barrier is crucial for preventing leaky gut syndrome and reducing the risk of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.
Potential Therapeutic Applications: Given its role in butyrate production and gut health, Eubacterium hallii and other butyrate-producing bacteria are being explored for their potential therapeutic applications in conditions associated with gut dysbiosis and inflammation. This includes research into probiotic formulations containing butyrate-producing bacteria for the management of gastrointestinal disorders.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| Taxonomy | Rank | Effect | Citations | Notation |
|---|
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.